Login
Toggle navigation
Videos
Categories
Trending
Unlocking Nigerian Telecom Growth: Optiva's Role in Digital MVNO Success | Robert Stabile, CEO & Chairman of the Board at Optiva Inc
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Rob Stabile is Chairman/Interim CEO at Optiva Inc.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Leadership and Teamwork in Game Development with Przemyslaw Marszal and Pawel Feldman | Przemyslaw Marszal, CEO , 11 bit studio Inc.
00:10:00
Tarek Müller, CEO of ABOUT YOU Holding SE, Discusses the Company's Rapid Growth| Tarek Müller, CEO , ABOUT YOU Holding SE.
00:10:00
Shifts in U.S. Monetary Policy: Anticipated Rate Cuts and Reduced Quantitative Tightening|Sh. Vikas Goel, Managing Director & CEO,PNB Gilts Ltd.
00:10:00
"During a six-month internship, experienced management roles at CPR Asset Management and Crédit Agricole S.A."
00:00:00
Tim Mitchell PhD FOUNDER & CEO, Sareum Holdings
00:10:00
Purepoint Uranium: Advancing Exploration in the Athabasca Basin
00:10:00
Journey Through Economic Challenges: A Perspective from UK Banking | Charlie Nunn, CEO, Lloyds Banking Group.
00:10:00
Winter 2024: Market Recap and Future Insights | Dmitriy Katsnelson, Investment Team, Wealthspire Advisors and Chris Maxey, Investment Team, Wealthspire Advisors
00:10:00
Brad Humphrey on Nikan's Nickel-Copper Projects and Exploration Progress
00:10:00
Fiercely Reliable Structures for Safety and Efficiency
00:10:00
Stuart Mckellar was named the 2019 GPC EGA Governance Professional of the Year | Horacio Galanti, CEO, Governance Professionals of Canada (TS)
00:10:00
Don Baxter on Focus Graphite's Unique Production Method and Rising Demand from Tesla